NDC 63323-280-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-280
- Requested NDC
- 63323-280-01
- Package NDCs from labels
- 63323-280-01, 63323-280-02, 63323-280-03, 63323-280-04, 63323-280-05, 63323-280-10, 63323-280-41, 63323-280-16, 63323-280-43, 63323-280-26, 63323-280-45, 63323-280-36
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Model AA-8565CV-ACT Model AA-8565CV - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-280-01 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 6 | |
| 63323-280-02 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-03 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 6 | |
| 63323-280-04 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-05 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 6 | |
| 63323-280-10 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-16 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-26 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-36 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-41 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 5 | |
| 63323-280-43 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 5 | |
| 63323-280-45 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241222_c794c95a-654e-48fe-9596-201fc122ff75.zip |
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_3747bbcd-783d-4baa-bb5b-b6827bf390e3.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Relief Extra Strength | ACETAMINOPHEN | DOLGENCORP, LLC | ce9f4e0d-43fb-499a-b8a2-a997a14841c4 | 2026-06-16 | Warnings | 362O9ITL9D |
| severe sinus congestion relief Maximum Strength | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Rite Aid Corporation | 51175d3e-e1c3-4e4d-ad32-61600e87568c | 2026-06-16 | Warnings | 362O9ITL9D |
| foster and thrive daytime cold and flu relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Strategic Sourcing Services LLC | 067ce5de-dbb4-4b65-8ec0-f4aacbe5e0a6 | 2026-06-16 | Warnings | 362O9ITL9D |
| Equate Severe Cold Cough and Flu | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | WALMART INC. | a35531d7-1a96-45cb-922f-61db085cde1f | 2026-06-16 | Warnings | TC2D6JAD40 362O9ITL9D |
| Pain Reliever | ACETAMINOPHEN | L.N.K. International, Inc. | 734cc3d2-6fc5-4dcc-93ed-0b57c1f01345 | 2026-06-15 | Warnings | 362O9ITL9D |
| Pain Relief Sinus Congestion | ACETAMINOPHEN, PHENYLEPHRINE HCL | Better Living Brands, LLC | 1d3d6397-0d92-4145-9a70-8bcc45bd0322 | 2026-06-15 | Warnings | 362O9ITL9D |
| RIGHT REMEDIES EXTRA STRENGTH Pain Relief PM Caplet | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Strive Pharmaceuticals Inc. | 2d63671d-cf7c-bbdd-e063-6294a90affef | 2026-06-15 | Warnings | TC2D6JAD40 362O9ITL9D |
| E-Z-GAS II | ANTACID/ANTIFLATULENT | E-Z-EM, INC. | 4e12e1cb-b033-076d-e054-00144ff8d46c | 2026-06-15 | Warnings | ETJ7Z6XBU4 |
| Shield by HEALTHY SKIN LAB MD SUNSCREEN | TITANIUM DIOXIDE, ZINC OXIDE | HEALTHY SKIN LAB LIMITED | 6838b754-9915-48ff-af35-5338dbd06ac4 | 2026-06-15 | Warnings | 15FIX9V2JP |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | 2968PHW8QP LX22YL083G |
| ACETAMINOPHEN | ACETAMINOPHEN | Granules India Limited | 00eb3e4b-1507-4c9a-83a5-ef50cb312753 | 2026-06-15 | Warnings | 362O9ITL9D |
| BM BM68 DROPS | ARGENTUM NIT, BARYTA CARB., DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | BM Private Limited | 53f9c99a-0f20-0358-e063-6394a90af4e0 | 2026-06-15 | Warnings | 451W47IQ8X |
| BM BM68 | ARGENTUM NIT, BARYTA CARB, DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5448c76a-2ecb-9402-e063-6294a90a6ad7 | 2026-06-15 | Warnings | 451W47IQ8X |
| TYLENOL Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | 59773893-09a8-47a2-943a-e9ea9da4458a | 2026-06-15 | Warnings | 362O9ITL9D |
| BM BIO28 ALCOHOL | CALC SULPH, CALC FLUOR, CALC PHOS, FERR PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT PHOS, NAT SULPH, NAT MUR, SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 544b66c4-49df-556f-e063-6394a90af3ed | 2026-06-15 | Warnings | ETJ7Z6XBU4 451W47IQ8X |
| Pain Relief | ACETAMINOPHEN | Shield Pharmaceuticals Corp. | 96eb7f9f-ff2d-4661-bbe6-1860aafe03f6 | 2026-06-15 | Warnings | 362O9ITL9D |
| Duralgina Extra Strength | ACETAMINOPHEN | Menper Distributors, Inc. | 544e3d7e-a759-384f-e063-6294a90a5baa | 2026-06-15 | Warnings | 362O9ITL9D |
| 70% | ISOPROPYL ALCOHOL | Meijer, Inc. | 7b1f93ff-5eeb-4da1-8f02-7c47d713689a | 2026-06-15 | Warnings, Adverse reactions | M003 ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Meijer, Inc. | 531cea18-9609-4d78-876d-3ba5d2d1e16f | 2026-06-15 | Warnings, Adverse reactions | M003 ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Meijer, Inc. | b0d302c2-58a0-4c3e-9c4a-fd34de40c034 | 2026-06-15 | Warnings, Adverse reactions | M003 ND2M416302 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.